Many Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with metastatic breast cancer receiving the PI3K inhibitor alpelisib, hyperglycemia often occurs, with a median time to onset of 16 days, according to a study published online Sept. 25 in Cancer….
Learn MoreBreast Cancer Drug Could Trigger Dangerous High Blood Sugar
MONDAY, Sept. 25, 2023 (HealthDay News) — For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.“This is a very …
Learn MoreQuímicos PFAS comunes vinculados a cánceres en mujeres
MIÉRCOLES, 20 de septiembre de 2023 (HealthDay News) — Los perjudiciales “químicos eternos” están ampliamente distribuidos en el medio ambiente, y una nueva investigación sugiere que representan un riesgo particular para la salud de las mujeres.Un nue…
Learn MoreSubsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin
TUESDAY, Sept. 19, 2023 (HealthDay News) — For female survivors of childhood cancer, the risk for subsequent breast cancer (SBC) is more than twofold higher for those who receive a cumulative dose of 200 mg/m² or more of doxorubicin compared with tho…
Learn MoreCommon PFAS Chemicals Linked to Cancers in Women
TUESDAY, Sept. 19, 2023 (HealthDay News) — Harmful “forever” chemicals are widespread in the environment, and new research hints they pose a particular health risk to women.A new study suggests women who are exposed to higher levels of per- and polyf…
Learn MoreMany Women May Overestimate Risks From Genes Tied to Breast Cancer
TUESDAY, Sept. 19, 2023 (HealthDay News) — Women who carry mutations in genes known as BRCA have an elevated risk of breast cancer. But a large, new study suggests that risk may be lower than generally believed — especially if a woman has no close r…
Learn MoreUse of AI Plus One Radiologist Noninferior for Detecting Breast Cancer
MONDAY, Sept. 18, 2023 (HealthDay News) — Double reading of screening mammograms by one radiologist plus artificial intelligence (AI) is noninferior to standard-of-care double reading by two radiologists, according to a study published online Sept. 8…
Learn MoreDiet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer
FRIDAY, Sept. 15, 2023 (HealthDay News) — A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the Journal of Clinical Oncology.Tara S…
Learn MoreEl aire contaminado podría aumentar el riesgo de cáncer de mama
JUEVES, 14 de septiembre de 2023 (HealthDay News) — Se ha sabido desde hace tiempo que la contaminación del aire perjudica el corazón y los pulmones, pero una nueva investigación sugiere que también podría aumentar el riesgo de cáncer de mama.Investi…
Learn MoreInterventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 (HealthDay News) — Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer survivors, according to a review pu…
Learn More